作者:
Su,X. [1]
;
Zhan,P. [2]
;
Gavine,P.R. [3]
;
Morgan,S. [4]
;
Womack,C. [5]
;
Ni,X. [6]
;
Shen,D. ;
Bang,Y.-J. ;
Im,S.-A. ;
HoKim,W. ;
Jung,E.-J. ;
Grabsch,H.I. ;
Kilgour,E.
作者单位:
AstraZeneca, Oncology Innovative Medicines, Alderley Park, Macclesfield, United Kingdom
[1]
Department of General Surgery, Renji Hospital, School of Medicine, Jiaotong University, Shanghai
[2]
Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea
[3]
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea
[4]
AstraZeneca Asia and Emerging Markets, Innovative Medicines, Shanghai, China
[5]
Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, United Kingdom
[6]
发布时间
2014-05-07